You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 020697

✉ Email this page to a colleague

NDA 020697 describes TASMAR, which is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. Additional details are available on the TASMAR profile page.

The generic ingredient in TASMAR is tolcapone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolcapone profile page.

Summary for 020697

Tradename:	TASMAR
Applicant:	Bausch
Ingredient:	tolcapone
Patents:	0

Pharmacology for NDA: 020697

Mechanism of Action	Catechol O-Methyltransferase Inhibitors

Suppliers and Packaging for NDA: 020697

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TASMAR	tolcapone	TABLET;ORAL	020697	NDA	Bausch Health US LLC	0187-0938	0187-0938-01	90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01)
TASMAR	tolcapone	TABLET;ORAL	020697	NDA AUTHORIZED GENERIC	Oceanside Pharmaceuticals	68682-938	68682-938-90	90 TABLET, FILM COATED in 1 BOTTLE (68682-938-90)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	100MG
Approval Date:	Jan 29, 1998	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	200MG
Approval Date:	Jan 29, 1998	TE:		RLD:	No

Expired US Patents for NDA 020697

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697-001	Jan 29, 1998	5,236,952	⤷ Get Started Free
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697-002	Jan 29, 1998	5,476,875	⤷ Get Started Free
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697-002	Jan 29, 1998	5,236,952	⤷ Get Started Free
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697-001	Jan 29, 1998	5,476,875	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.